in this issue
EnviroTech :: Biotech
Teva to Acquire Ratiopharm for $4.9 Billion
10:46 PM MDT | March 18, 2010 | Deepti Ramesh
Teva Pharmaceutical Industries (Petah Tikva, Israel), the leading generics pharmaceutical company in the world, says it has entered into a definitive agreement to acquire Ratiopharm (Ulm, Germany), the second largest generics producer in Germany and the sixth largest generics drug company worldwide, for an enterprise value of €3.62 billion ($4.9 billion). Teva expects to complete the acquisition by the end of 2010. The acquisition will position Teva as the leading generics company in Europe, Teva says. Ratiopharm had sales of about €1.6 billion ($2.2...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee